Crinetics Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRNX and other ETFs, options, and stocks.

About CRNX

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. 

CEO
Scott R. Struthers
CEOScott R. Struthers
Employees
290
Employees290
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2008
Founded2008
Employees
290
Employees290

CRNX Key Statistics

Market cap
5.22B
Market cap5.22B
Price-Earnings ratio
-15.44
Price-Earnings ratio-15.44
Dividend yield
—
Dividend yield—
Average volume
571.73K
Average volume571.73K
High today
$57.63
High today$57.63
Low today
$56.10
Low today$56.10
Open price
$56.99
Open price$56.99
Volume
112.60K
Volume112.60K
52 Week high
$62.53
52 Week high$62.53
52 Week low
$32.22
52 Week low$32.22

Analyst ratings

92%

of 13 ratings
Buy
92.3%
Hold
7.7%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.